Tag Archives: MRNA

Trading floor screens showing a biotech stock gapping higher after clinical trial data

Moderna Stock (MRNA): Inside the Phase 3 Cancer Vaccine Win

Moderna Stock (MRNA): Inside the Phase 3 Cancer Vaccine Win 1. Introduction On 19 August 2026, Moderna closed up 176.97% at $174.38. It was the best day in the company’s history and the largest single-session gain in the S&P 500 that day, adding roughly $45 billion of market value in a few hours. The catalyst…

Read more